Biodesix outlines $106M–$112M 2026 revenue target as sales expansion drives 41% Q4 growth [Seeking Alpha]
Biodesix, Inc. (BDSX)
Company Research
Source: Seeking Alpha
CEO Scott Hutton indicated that Biodesix is prioritizing revenue growth, operational leverage, and pipeline advancement in 2025 and 2026. The company achieved a 41% revenue increase in Q4, improved gross margins to 83%, and reached adjusted Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Revenue and margin growth are driven by expanded and maturing sales force, increasing clinical adoption of Nodify tests, entry into primary care, and strategic partnerships. Management emphasizes continued operational improvements, productivity gains, and disciplined spending, with sustainable EBITDA positivity seen as likely due to sales force expansion and revenue growth. Seasonality, weather disruptions in Q1, uncertainty in collections, and the timing/payout of clinical study data are identified as the main risks and headwinds. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
BDSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDSX alerts
High impacting Biodesix, Inc. news events
Weekly update
A roundup of the hottest topics
BDSX
News
- Are Medical Stocks Lagging Biodesix (BDSX) This Year? [Yahoo! Finance]Yahoo! Finance
- Biodesix (BDSX) was upgraded by William Blair from "market perform" to "outperform".MarketBeat
- Biodesix (BDSX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Biodesix Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights [Yahoo! Finance]Yahoo! Finance
BDSX
Earnings
- 2/26/26 - Beat
BDSX
Sec Filings
- 2/26/26 - Form 10-K
- 2/26/26 - Form 8-K
- 2/23/26 - Form 4
- BDSX's page on the SEC website